Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.3 |
mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.059 | 0.3 |
mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.3 |
mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.072 | 0.3 |
mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |